Becton, Dickinson and Company BDX Total debt

Total debt at other companies

AbbottABT

$32.61B+143%

Baxter InternationalBAX

$224M-8.9%

Bio-Rad LaboratoriesBIO

$987.3M-28.4%

TFX

TeleflexTFX

$2.78B+38.6%

Thermo Fisher ScientificTMO

$39.18B+4.6%

West Pharmaceutical ServicesWST

$316.5M+2.7%

FAQ

What is Becton, Dickinson and Company's total debt?

Becton, Dickinson and Company (BDX) reported total debt of $14.71B in Q1 2026.

How has Becton, Dickinson and Company's total debt changed year-over-year?

Becton, Dickinson and Company's total debt decreased by 16.8% year-over-year, from $17.67B to $14.71B.

What is the long-term trend for Becton, Dickinson and Company's total debt?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's total debt has grown at a 1.7% compound annual growth rate (CAGR), from $17.24B to $18.46B.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.